Spinraza Nusinersen 12mg/5ml Injection

SPINRAZA (Nusinersen) is a prescription drug used to treat spinal muscular atrophy (SMA) in pediatric and adult patients. SMA is a rare genetic disease caused by a low level of protein in the motor neuron that are responsible for normal muscle functioning .The lack of protein causes motor neuron loss, progressive muscle weakness and may lead to premature death from respiratory failure. This is mostly observed among children and young adults. SPINRAZA increases the body’s ability to produce SMN protein critical to the health of motor neurons.

Manufacturer :  Biogen Inc.

Strengths available :  12mg / 5ml

Form :  Injection

Storage :  Store at temperature between 2°C – 8°C.

FDA Approval :  USA Approved

Approval date: December 23, 2016

Dosage :  

Initial: 4 loading doses; administer the first 3 doses at 14-day intervals and the fourth dose 30 days after the third dose

Maintenance: One dose every 4 months

Common side effects of Spinraza include lower respiratory infection, upper respiratory infection, constipation, teething, congestion, ear infection and scoliosis.

Pack of 1 Vial